Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS.

Neurol Neuroimmunol Neuroinflamm · 2021 · PMC7676421 · PMID 33203651

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

showed a trendno p-value reported

Compared with untreated patients with MS, the IL-1β gene expression also showed a trend to be lower, which, however, failed to reach significance ( figure 3B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.